Method of screening for inhibitors of osteopontin
US7662633B2 · kind B2 · utility
4Cited by
0References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 22, 2006 |
| Grant date | Feb 16, 2010 |
| Priority date | — |
| Expiry date | Mar 6, 2027 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/52
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Amino acids 136 to 142 and amino acids 162 to 168 of human osteopontin constitute two sites at which osteopontin interacts with α4 integrins. Products capable of disrupting those interactions are useful in therapy, particularly in the treatment of inflammatory diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.